SCHEDULE 13G: Progeny 3, Inc. and Jon Hemingway Disclose 12.3% Stake in ACUREN CORP

Investment manager Progeny 3, Inc., controlled by Jon Hemingway, has disclosed a significant 12.3% beneficial ownership stake in ACUREN CORP, totaling 15 million shares.

Summary

• Progeny 3, Inc., a Washington corporation, and Jon Hemingway, a U.S. citizen who controls Progeny 3, Inc., have jointly filed a Schedule 13G.
• The filing discloses beneficial ownership of 15,000,000 shares of ACUREN CORP Common Stock.
• This stake represents 12.3% of ACUREN CORP's outstanding Common Stock.
• The percentage is calculated based on the number of shares outstanding as reported in the Company's Form 10-K filed on March 27, 2025.
• Progeny 3, Inc. and Jon Hemingway hold sole voting and sole dispositive power over these 15 million shares.
• The Reporting Persons do not directly own any Common Stock but maintain voting and dispositive power through investment agreements with certain accounts (the 'Accounts').
• The Accounts have the right to receive dividends or proceeds from the sale of these securities.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's performance or outlook. It simply reports a significant stake.

Positives

• The disclosure of a significant 12.3% stake by an investment manager and its controlling individual may signal confidence in ACUREN CORP's future prospects.
• A substantial institutional holding can provide stability to the shareholder base.

Industry Context

This filing is a standard disclosure of significant ownership by an investment entity, common across all industries. It does not provide specific insights into ACUREN CORP's operational performance or industry trends, but rather indicates a notable investment position.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder can influence investor perception and potentially provide a sense of stability or validation for the company's stock.

Key Dates

Keywords

ACUREN CORP, Schedule 13G, Beneficial Ownership, Progeny 3 Inc, Jon Hemingway, Common Stock, Institutional Investor, Shareholder Disclosure, SEC Filing